“The American Society of Addiction Medicine (ASAM) announced the release of its National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use (Practice Guideline). The Practice Guideline will assist clinicians prescribing pharmacotherapies to patients with addiction related to opioid use.
It addresses knowledge gaps about the benefits of treatment medications and their role in recovery, while guiding evidence-based coverage standards by payers.
Medications are both clinical and cost-effective interventions. While the effectiveness of medications has been researched and documented, their utilization is low and coverage varies dramatically. Less than 30% of treatment programs offer medications and less than half of eligible patients in those programs receive medications.
According to Dr. Jeffrey Goldsmith, ASAM President, “Opioid addiction is a chronic, life-threatening disease with significant medical, emotional, criminal justice and societal costs. This guideline is the first to address all the available medications to treat opioid addiction. It will help save lives.”
Read more at: http://www.prnewswire.com/news-releases/american-society-of-addiction-medicine-releases-national-practice-guideline-for-the-use-of-medications-in-the-treatment-of-addiction-involving-opioid-use-300092961.html
Source: American Society of Addiction Medicine – June 2, 2015